All of the participants in the Phase II trial were able to tolerate nearly 2 peanut kernels at the end of two months.
Tag: FDA breakthrough treatment
Novel Eczema Drug Giving Patients New Lease On Life
New York researchers at Mount Sinai are easing the relentless itch of eczema with a new drug. Dubbed a “breakthrough” therapy by the FDA, it treats eczema’s source rather than just its symptoms.